Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a ...

Research analysts at Zacks Research raised their Q2 2025 EPS estimates for Phibro Animal Health in a report released on ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

It might be of some concern to shareholders to see the Phibro Animal Health Corporation ( NASDAQ:PAHC) share price down 16% in the last month. But looking back over the last year, the returns have ...

The global Veterinary Vaccines market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion in 2024 and an impressive US$13.33 billion by 2029.

Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite ...

While the historical EPS growth rate for Phibro is 0.9%, investors should actually focus on the projected growth. The company's EPS is expected to grow 35.7% this year, crushing the industry average, ...

Read Our Latest Report on PAHC Phibro Animal Health Trading Down 6.7 % Shares of PAHC opened at $20.05 on Thursday. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of ...